1 |
Yeung CLS, Yam JWP. Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.013] [Reference Citation Analysis]
|
2 |
Tey SK, Wong SWK, Tung Chan JY, Mao X, Ng TH, Yeung CLS, Leung Z, Fung HL, Tang AHN, Wong DKH, Mak L, Yuen M, Sin C, Ng IO, Ma SKY, Lee TKW, Cao P, Zhong K, Gao Y, Yun JP, Ping Yam JW. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma. Journal of Hepatology 2021. [DOI: 10.1016/j.jhep.2021.12.005] [Reference Citation Analysis]
|
3 |
Bushey RT, Gottlin EB, Campa MJ, Patz EF Jr. Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis. PLoS One 2021;16:e0252577. [PMID: 34133431 DOI: 10.1371/journal.pone.0252577] [Reference Citation Analysis]
|
4 |
Irmscher S, Zipfel SLH, Halder LD, Ivanov L, Gonzalez-Delgado A, Waldeyer C, Seiffert M, Brunner FJ, von der Heide M, Löschmann I, Wulf S, Czamara D, Papac-Milicevic N, Strauß O, Lorkowski S, Reichenspurner H, Holers MV, Banda NK, Zeller T, Binder EB, Binder CJ, Wiech T, Zipfel PF, Skerka C. Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease. Sci Rep 2021;11:22511. [PMID: 34795372 DOI: 10.1038/s41598-021-02011-w] [Reference Citation Analysis]
|